(2R,5S,6S)-2-[[(3S,4R,6S)-3-[(2S,4R,5S)-5-[(2S,4S,5R)-4-[(2R,5S,6S)-3-[(2S,4R,5S)-5-[(2S,4S,5S)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,4R,5R)-4-hydroxy-5-methyl-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-3-methyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,4S,5S)-3-[(2S,4R,5S)-5-[(2S,4S,5S)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,4R,5R)-4-hydroxy-5-methyl-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-3-methyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-3,5-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-3-methyloxan-2-yl]oxy-4-hydroxy-5-methyl-6-propan-2-yloxan-2-yl]methoxy]-6-methyloxane-3,4,5-triol

• 分子结构分类: 有机化合物 - 有机聚合物 - 多糖
• 英文名称: (2R,5S,6S)-2-[[(3S,4R,6S)-3-[(2S,4R,5S)-5-[(2S,4S,5R)-4-[(2R,5S,6S)-3-[(2S,4R,5S)-5-[(2S,4S,5S)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,4R,5R)-4-hydroxy-5-methyl-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-3-methyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,4S,5S)-3-[(2S,4R,5S)-5-[(2S,4S,5S)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,4R,5R)-4-hydroxy-5-methyl-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-3-methyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-3,5-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-3-methyloxan-2-yl]oxy-4-hydroxy-5-methyl-6-propan-2-yloxan-2-yl]methoxy]-6-methyloxane-3,4,5-triol
• 化学式: C₈₅H₁₄₈O₅₅
• 分子量: 2050.0
• InChiKey: BCANIYWWLPUILY-OTYLHKOOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -13.6
• 重原子数：
  140
• 可旋转键数：
  38
• 环数：
  12.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  860
• 氢给体数：
  32
• 氢受体数：
  55

文献信息

• PARATHYROID HORMONE ANALOGS, COMPOSITIONS AND USES THEREOF
  申请人：Danishefsky Samuel J.

  公开号：US20140228293A1

  公开（公告）日：2014-08-14

  The present invention provides parathyroid hormone and/or parathyroid hormone-related protein analogs, compositions thereof and methods thereto.